John Stratton Net Worth

The estimated Net Worth of John G Stratton is at least $830 Thousand dollars as of 31 January 2019. Mr. Stratton owns over 3,455 units of Abbott Laboratories stock worth over $529,024 and over the last 6 years he sold ABT stock worth over $0. In addition, he makes $300,977 as Independent Director at Abbott Laboratories.

Mr. Stratton ABT stock SEC Form 4 insider trading

John has made over 1 trades of the Abbott Laboratories stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 3,455 units of ABT stock worth $249,866 on 31 January 2019.

The largest trade he’s ever made was buying 3,455 units of Abbott Laboratories stock on 31 January 2019 worth over $249,866. On average, John trades about 19 units every 0 days since 2014. As of 31 January 2019 he still owns at least 6,400 units of Abbott Laboratories stock.

You can see the complete history of Mr. Stratton stock trades at the bottom of the page.

John Stratton biography

John G. Stratton is Director of the Company. Mr. Stratton has served as Executive Vice President and President of Global Operations since February 2015. Previously, he served as Executive Vice President and President of Global Enterprise and Consumer Wireline from April 2014 to February 2015, as President of Verizon Enterprise Solutions from January 2012 to April 2014, and as Chief Operating Officer and Executive Vice President of Verizon Wireless from October 2010 to January 2012. Since October 2012, Mr. Stratton has also served as a member of The President’s National Security Telecommunications Advisory Committee. Through his executive leadership at Verizon Communications, Mr. Stratton contributes extensive business and management experience operating a global public company such as Abbott, including valuable insights on corporate strategy and risk management. His service on the National Security Telecommunications Advisory Committee enables him to provide government perspective and experience in a highly regulated industry.

What is the salary of John Stratton?

As the Independent Director of Abbott Laboratories, the total compensation of John Stratton at Abbott Laboratories is $300,977. There are 14 executives at Abbott Laboratories getting paid more, with Miles White having the highest compensation of $24,254,200.

How old is John Stratton?

John Stratton is 58, he’s been the Independent Director of Abbott Laboratories since 2017. There are 10 older and 6 younger executives at Abbott Laboratories. The oldest executive at Abbott Laboratories is Samuel Scott, 74, who is the Independent Director.

What’s John Stratton’s mailing address?

John’s mailing address filed with the SEC is 100 ABBOTT PARK ROAD, , ABBOTT PARK, IL, 60064.

Insider trading at Abbott Laboratories

Over the last 19 years, insiders at Abbott Laboratories have traded over $300,124,202 worth of Abbott Laboratories stock and bought 1,026,437 units worth $44,673,718 . The most active insider traders include Miles D White, Richard A Gonzalez, and Glenn F Tilton. On average, Abbott Laboratories executives and independent directors trade stock every 8 days with the average trade being worth of $3,036,946. The most recent stock trade was executed by Randel William Woodgrift on 23 October 2019, trading 21,000 units of ABT stock currently worth $1,691,340.

What does Abbott Laboratories do?

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

What does Abbott Laboratories’s logo look like?

Complete history of Mr. Stratton stock trades at Abbott Laboratories and Verizon Communications

Abbott Laboratories executives and stock owners

Abbott Laboratories executives and other stock owners filed with the SEC include:

  • Miles White, Chairman of the Board, Chief Executive Officer
  • Robert Ford, President, Chief Operating Officer
  • Brian Yoor, Chief Financial Officer, Executive Vice President – Finance
  • Hubert Allen, Executive Vice President, General Counsel, Secretary
  • Daniel Salvadori, Senior Vice President – Established Pharmaceuticals, Latin America.
  • Robert Alpern, Independent Director
  • Sally Blount, Independent Director
  • Glenn Tilton, Independent Director
  • Samuel Scott, Independent Director
  • William Osborn, Lead Independent Director
  • Roxanne Austin, Independent Director
  • Edward Liddy, Independent Director
  • Nancy McKinstry, Independent Director
  • Phebe Novakovic, Independent Director
  • John Stratton, Independent Director
  • Daniel Starks, Independent Director
  • Michelle Kumbier, Independent Director
  • Darren McDew, Director
  • Jaime Contreras, Senior Vice President – Core Laboratory Diagnostics, Commercial Operations
  • Jared Watkin, Senior Vice President
  • Andrew H Lane, Senior Vice President
  • Robert E Funck, Senior Vice President
  • Sean Shrimpton, Senior Vice President
  • John M Capek, Executive Vice President
  • Deepak S. Nath, Senior Vice President
  • Joseph J Manning, Senior Vice President
  • Roger Bird, Senior Vice President
  • Brian J Blaser, Senior Vice President
  • Stephen R Fussell, Senior Vice President
  • Michael J Warmuth, Senior Vice President
  • Eric S Fain, Senior Vice President
  • Lisa D Earnhardt, Executive Vice President
  • Sharon J Bracken, Senior Vice President
  • Michael T Rousseau, Pres., Cardiovasc. & Neuromod.
  • Charles Brynelsen, Senior Vice President
  • Michael J Pederson, Senior Vice President
  • Alejandro D Wellisch, Senior Vice President
  • Sammy Karam, Senior Vice President
  • Randel William Woodgrift, Senior Vice President
  • Christopher J Scoggins, Senior Vice President
  • Richard W Ashley, Executive Vice President
  • Andrea F Wainer, Executive Vice President
  • John F Ginascol, Executive Vice President
  • Jean Yves Pavee, Senior Vice President
  • W James Farrell, Director
  • Thomas C Freyman, Senior Vice President
  • Georges H. De Vos, Senior Vice President
  • Katherine C. Doyle, Senior Vice President
  • J. Scott White, Senior Vice President
  • Charles D Foltz, Senior Vice President
  • Murthy V Simhambhatla, Senior Vice President
  • Thomas G Frinzi, Senior Vice President
  • John C Landgraf, Senior Vice President
  • Greg W Linder, Vice President
  • Heather L Mason, Senior Vice President
  • Paul K Magill, Senior Vice President
  • A. David Forrest, Senior Vice President
  • H Laurance Fuller, Director
  • Carlos Alban, Senior Vice President
  • James V Mazzo, Senior Vice President
  • Holger A Liepmann, Senior Vice President
  • William D Smithburg, Director
  • Laura J Schumacher, Senior Vice President
  • David Owen, Director
  • Edward L Michael, Senior Vice President
  • Richard A Gonzalez, Chief Operating Officer
  • Donald V Jr Patton, Senior Vice President
  • William M Daley, Director
  • Robert B Hance, Senior Vice President
  • Mary T Szela, Senior Vice President
  • Roy S Roberts, Director
  • Corlis D Murray, Senior Vice President
  • Thomas F Chen, Senior Vice President
  • Olivier Bohuon, Senior Vice President
  • James L Tyree, Senior Vice President
  • W Ann Reynolds, Director
  • Boone Jr Powell, Director
  • Mary K Moreland, Executive Vice President
  • Edward J Fiorentino, Senior Vice President
  • Gary E Mccullough, Senior Vice President
  • Jeffrey M Leiden, President & COO
  • Jack M Greenberg, Director
  • Joseph M Nemmers, Senior Vice President
  • John R Walter, Director
  • Jeffrey R Binder, Senior Vice President
  • William G Dempsey, Senior Vice President
  • A Barry Rand, Director
  • Thomas M Wascoe, Senior Vice President
  • Christopher B Begley, Senior Vice President
  • Lance B Wyatt, Senior Vice President
  • Guillermo A Herrera, Senior Vice President
  • Lasa Jose M De, Senior Vice President